The ViBiA clinical study
A multicenter, double‑blind clinical study designed to assess the ability of natural nutraceutical active ingredients with high antioxidant potential to reach the vitreoretinal district and exert an effective anti‑inflammatory action. The trial is led by Dr. Luca Ventre, Director of the Ophthalmology Unit at the Beauregard Hospital in Aosta, and involves six national university and hospital centers.
News from Cosmoprof
Cosmoprof è l'evento di riferimento per le aziende e i professionisti di tutte le aree dell'industria cosmetica mondiale. I protagonisti del settore, esperti di bellezza e relatori provenienti da tutto il mondo esplorano gli argomenti più attuali dell'industria cosmetica per anticipare i trend del futuro. Le interviste realizzate propongono alcuni dei temi che rappresentano le tendenze emergenti.
FAST 2025 - Young People and Science
Exhibition of 40 scientific projects presented by young students aged between 14 and 20. The national competition, organized by FAST (Federation of Scientific and Technical Associations), allows the winning students to participate in the European-scale competition EUCYS (European Union Contest for Young Scientists).
Italfarmaco, a flexible industrial model
Two innovations concerning the treatment of serious neuromuscular diseases (Amyotrophic Lateral Sclerosis and Duchenne Muscular Dystrophy) are presented by the Chief Medical Officer of the Italfarmaco Group, Paolo Bettica. The event offers the opportunity for the Group CEO, Paolo Zambonardi, to underline that these results are the effect of a flexible and articulated business strategy, based on sectors of business activity, apparently irreconcilable but in reality synergistic: basic research and “incremental innovation”.